Label: BONINE- meclizine hydrochloride tablet, chewable

  • NDC Code(s): 65197-297-08, 65197-297-12, 65197-297-16, 65197-297-24
  • Packager: WellSpring Pharmaceutical Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 21, 2025

If you are a consumer or patient please visit this version.

  • Active ingredient (in each tablet)

    Meclizine HCl 25 mg

  • Purpose

    Antiemetic

  • Uses

    prevents and treats nausea, vomiting or dizziness associated with motion sickness

  • Warnings

    Do not use 

    in children under 12 years of age unless directed by a doctor.

    Ask a doctor before use if you have

    • difficulty in urination due to enlargement of the prostate gland
    • glaucoma
    • a breathing problem such as emphysema or chronic bronchitis

    Ask a doctor or pharmacist before use if you are

    taking sedatives or tranquilizers.

    When using this product

    • avoid alcoholic beverages
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • drowsiness may occur
    • use caution when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding, 

    ask a health professional before use.

    Keep out of reach of children. 

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • dosage should be taken one hour before travel starts
    • chew or crush tablets completely before swallowing; do not swallow tablets whole
    • adults and children 12 years and over: take 1 to 2 chewable tablets once daily or as directed by a doctor
  • Other information

    • store at 25˚C (77˚F); excursions permitted between 15˚-30˚C (59˚-86˚F)
    • see end flap for expiration date and lot number
    • protect from heat and humidity
  • Inactive ingredients

    colloidal silicon dioxide, dextrose, FD&C red #40 aluminum lake, flavor, lactose monohydrate, magnesium stearate, pregelatinized starch, propylene glycol, saccharin sodium, silicon dioxide

  • Questions or comments?

    1 (844) 241-5454 or www.bonine.com 

  • Dist. by:

    WellSpring Pharmaceutical
    Corporation Sarasota, FL 34243
    ©2024 WellSpring Pharmaceutical Corporation

    TAMPER EVIDENT: DO NOT USE IF PRINTED TEAR STRIP IS BROKEN OR MISSING

    MONEY BACK GUARANTEE

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL 65197-297

    *Less drowsy vs. Dramamine® dimenhydrinate. Dramamine® is a registered trademark of Medtech Products Inc.

    NEW LOOK! Same great formula

    9X the Adventure** Meclizine HCl • Antiemetic 25 mg

    CT029512RE

    Bonine 12 ct

  • INGREDIENTS AND APPEARANCE
    BONINE 
    meclizine hydrochloride tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65197-297
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO) (MECLIZINE - UNII:3L5TQ84570) MECLIZINE HYDROCHLORIDE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    FD&C RED NO. 40 (UNII: WZB9127XOA)  
    SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Product Characteristics
    ColorpinkScore2 pieces
    ShapeROUNDSize9mm
    FlavorRASPBERRYImprint Code BONINE
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:65197-297-081 in 1 BOX04/01/2025
    18 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:65197-297-121 in 1 BOX04/01/2025
    212 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:65197-297-162 in 1 BOX04/01/2025
    38 in 1 BLISTER PACK; Type 0: Not a Combination Product
    4NDC:65197-297-243 in 1 CARTON04/01/2025
    48 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00904/01/2025
    Labeler - WellSpring Pharmaceutical Corporation (110999054)